$1.4 Trillion Helium Crisis Creates Booming Opportunity For Investors
Did you know that helium is one of the most valuable resources on the planet? That's because almost every big tech company depends on it. And the world's helium supply is running dangerously low. That's bad news for big tech, but great news for helium investors.
And This One Company Just Made A Helium Discovery
John T. Treace, insider at Treace Medical Concepts
John T. Treace Insider Alerts

Get notified the next time John T. Treace buys or sells Treace Medical Concepts stock. Enter your email address below to get our daily insider buying and selling report.

John T. Treace Insider Information

John T. Treace has over 25 years of experience in medical device marketing, sales, and general management. Mr. Treace founded our company in January 2014 and has served as our Chief Executive Officer and a member of our board of directors since our inception. Mr. Treace is the former Senior Vice President of US Sales and Global Marketing for Wright Medical Group, Inc., a medical device company, acquired by Stryker Corporation (NYSE: SYK) in November 2020. During a 12-year tenure with Wright, Mr. Treace served in a number of senior management roles including Vice President, Biologics and Extremities and Senior Director of Biologics Marketing. Before that, Mr. Treace held positions at Xomed Surgical Products, Inc., including as Director of Marketing and as Senior Product Manager, and with TreBay Medical Corp as Advertising & Marketing Director.  Mr. Treace also served on the board of directors of ENTrigue Surgical, acquired by Arthrocare Corporation in July 2013. Mr. Treace holds a B.S. in Finance from Seattle University.

What is John T. Treace's net worth?

The estimated net worth of John T. Treace is at least $192.26 million as of April 27th, 2021. Mr. Treace owns 11,171,385 shares of Treace Medical Concepts stock worth more than $192,259,536 as of November 29th. This net worth approximation does not reflect any other investments that Mr. Treace may own. Learn More.

How old is John T. Treace?

Mr. Treace is currently 49 years old. There are 6 older executives and no younger executives at Treace Medical Concepts. Learn More.

How do I contact John T. Treace?

The corporate mailing address for Mr. Treace and other Treace Medical Concepts executives is 203 FORT WADE RD. SUITE 150, PONTE VEDRA FL, 32081. Treace Medical Concepts can also be reached via phone at 904-373-5940 and via email at [email protected]

Has John T. Treace been buying or selling shares of Treace Medical Concepts?

Over the course of the past ninety days, John T. Treace has sold $3,945,181.00 in Treace Medical Concepts stock. Most recently, John T. Treace sold 56,000 shares of the business's stock in a transaction on Wednesday, November 24th. The shares were sold at an average price of $17.84, for a transaction totalling $999,040.00.

Who are Treace Medical Concepts' active insiders?

Treace Medical Concepts' insider roster includes Sean Scanlan (SVP), Thomas Timbie (Director), James Treace (Director), and John Treace (CEO).

Are insiders buying or selling shares of Treace Medical Concepts?

During the last twelve months, Treace Medical Concepts insiders bought shares 1 times. They purchased a total of 10,000 shares worth more than $170,000.00. During the last twelve months, insiders at the sold shares 13 times. They sold a total of 6,301,372 shares worth more than $108,121,242.02. The most recent insider tranaction occured on November, 24th when Director James T Treace sold 17,000 shares worth more than $303,110.00.

Information on this page was last updated on 11/24/2021.

John T. Treace Insider Trading History at Treace Medical Concepts

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/24/2021Sell56,000$17.84$999,040.00View SEC Filing Icon  
11/22/2021Sell53,000$18.35$972,550.00View SEC Filing Icon  
10/22/2021Sell58,089$20.74$1,204,765.86View SEC Filing Icon  
10/20/2021Sell30,827$24.94$768,825.38View SEC Filing Icon  
4/27/2021Sell5,253,805$17.00$89,314,685.0011,171,385View SEC Filing Icon  
See Full Table

John T. Treace Buying and Selling Activity at Treace Medical Concepts

This chart shows John T Treace's buying and selling at Treace Medical Concepts by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Treace Medical Concepts Company Overview

Treace Medical Concepts logo
Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of device and/or biologic solutions for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical improvement. The company also provides Lapiplasty Mini-Incision precision system. In addition, it offers products to address ancillary surgical procedures, including akin osteotomies, weil osteotomies, intercuneiform stabilization, lesser tarsometatarsal joint fusions, and autograft bone harvesting, as well as for MTP fusion. Treace Medical Concepts, Inc. was incorporated in 2014 and is headquartered in Ponte Vedra Beach, Florida.
Read More

Today's Range

Now: $17.21
Low: $16.86
High: $18.36

50 Day Range

MA: $23.70
Low: $17.52
High: $29.35

2 Week Range

Now: $17.21
Low: $16.57
High: $37.17

Volume

7,473 shs

Average Volume

243,326 shs

Market Capitalization

$915.11 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A
All Electric Commitment From GM, Volkswagen, Could Put Lithium Stock In A Supercycle
More automakers are pledging to go "fully electric" by 2035. NOW is the perfect time to get in on the "EV Revolution." And the best way to potentially do that, is to skip over the overvalued electric vehicle stocks...
Look At This Under-The-Radar Lithium Company